INM NeuroProteomics V2


The new INM Neuroproteomics platform aims at using the latest technological developments in mass spectrometry for the discovery and investigation of the role of peptides, proteins and their post-translationnal modifications (PTMs) in fundamental and translationnal research in Neuroscience. The Neuroproteomics Plateform is connected with the CHU Clinical Proteomics Platform (, also scientifically led by Pr C Hirtz and operationally by Dr Jérôme Vialaret (CHU).







Hirtz Christophe